Gene Therapy Development

Rapid Quantitation of AAV Capsids in Bioprocess Development for Gene Therapy Using Octet^®️ BLI

Adeno-associated virus (AAV), with low immunogenicity and toxicity, has become one of the most promising viral vectors used for delivery of genetic material in gene therapy. AAV vector development and production at industrial scale requires an efficient method for accurate quantitation of viral capsids in both upstream and downstream bioprocessing.

Octet^® Bio-Layer Interferometry (BLI) systems in combination with the Octet^® AAVX Biosensors offer a rapid, label-free, and high-throughput method for quantification of AAV capsids. This video compares the Octet^® AAVX biosensor workflow to that of ELISA at various stages in bioprocess development.

Complete Form to Download the Document

First Name *

Last Name *

E-Mail *

Phone Number

Company *

Postal Code *

Country *

Which of These Statements Describes You Best? *

Contact me, I’m interested in implementing Raman spectroscopy with Sartorius bioreactors Contact me, I’m interested in implementing Raman spectroscopy in Ambr® Contact me, I’m interested in implementing Raman spectroscopy in Biostat STR® Don't contact me, I'm just learning.

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy